Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

The effects of sulforaphane treatment on the expression of microRNAs in Caco-2 and CCD-841 cells

ABSTRACT: The effect of sulforaphane on the expression of microRNAs in colorectal adenocarcinoma Caco-2 cells and non-cancerous colorectal CCD-841 cells was investigated, in order to help ascertain the roles of microRNAs in the anti-cancer effects of sulforaphane.

ORGANISM(S): Homo sapiens

PROVIDER: GSE89363 | GEO | 2020/06/30

REPOSITORIES: GEO

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
		Other

Items per page:

1 - 1 of 1

Similar Datasets

Transcription profiling of human colon Caco-2 cells treated with sulforaphane (SF)

Project description:Effect of sulforaphane (SF) on human colon caco-2 cells after 24h treatment

2005-07-01 | E-MEXP-170 | biostudies-arrayexpress

Homo sapiens

Project description:The effects of sulforaphane treatment on the expression of microRNAs in Caco-2 and CCD-841 cells

| PRJNA351880 | ENA

microRNA expression profiling of human colorectal cancer cell lines: HRT-18 vs. Caco-2

Project description:MicroRNAs regulate the biological aggressiveness of colorectal cancer (CRC) cells and might serve as potential prognostic factors and therapeutic targets. In this study, we therefore globally profiled microRNAs associated with aggressive growth in CRC cells, in an attempt to identify novel prognostic biomarkers in CRC patients. In detail, two different CRC cell lines (Caco-2 and HRT-18) with completely different growth rates and different E-cadherin expression were profiled for differences in more than 1000 human microRNAs by using microarray technology. Two-condition experiment, HRT-18 vs. Caco-2. Biological replicates: 3, independently grown and harvested. On each array, one BR of HRT-18 cells was directly compared to one BR of Caco-2 cells (serving as reference sample). All hybridizations were repeated with reversed dye assignment (dye-swap) as technical replicates.

2014-01-13 | E-GEOD-53095 | biostudies-arrayexpress

aCGH analysis of human colon cancer C85 cell genome.

Project description:Chromosomal aberrations of C85 cell genome were identified by referral to normal colon epithelial CCD 841 CoN cell genome and Agilent Reference genomic DNA.

2018-05-24 | GSE114817 | GEO

microRNA expression profiling of human colorectal cancer cell lines: HRT-18 vs. Caco-2

2014-01-13 | GSE53095 | GEO

long read RNA-seq from Caco-2 (ENCSR580IDG)

Project description:ENC4_511, ENC4_512 Caco-2 rep1 human colorectal adenocarcinoma (epithelial) For data usage terms and conditions, please refer to http://www.genome.gov/27528022 and http://www.genome.gov/Pages/Research/ENCODE/ENCODE_Data_Use_Policy_for_External_Users_03-07-14.pdf

2022-12-04 | GSE219418 | GEO

Difference between sulforaphane and sulforaphene in colon cancer

Project description:Sulforaphane and sulforaphene are isothiocyanate compounds derived from cruciferous vegetables that have demonstrated antiproliferative properties against colon cancer. However, the underlying mechanism of action of these two compounds is yet to be elucidated. The present study aimed to study the effects of sulforaphane and sulforaphene on colon cancer by next-generation sequencing (NGS).

2021-05-15 | GSE174444 | GEO

Effects of Wnt3A on the transcriptome of CCD-18Co human colon fibroblasts

Project description:Purpouse: To compare the transriptome of CCD-18Co human colon fibroblasts treated with vehicle or Wnt3A. Methods: We treated triplicate plates of CCD-18Co cells with vehicle or Wnt3A during 24 h. Afterwards, we obtained total RNA and used it in RNA-seq experiments. Results: Our analysis rendered a total of 1136 differentially expressed genes (FDR<0.05), of which 662 were up-regulated and 474 were downregulated in response to Wnt3A. Conclusions: Wnt3A regulates a wide set of genes in CCD-18Co human colon fibroblasts

2017-10-30 | GSE89124 | GEO

cDNA microarray analysis of sulforaphane effect on mouse acute lung injury caused by hyperoxia

Project description:Protective roles of Nrf2, a key transcription factor for antioxidant and defense genes, have been determined in oxidative lung injury, and health benefits of Nrf2 agonists including sulforaphane have been demonstrated. The current study was designed to investigate the effect of sulforaphane on model acute lung injury and sulforaphane-mediated transcriptome changes in mouse lungs. Adult mice genetically deficient in Nrf2 (Nrf2-/-) and wild-type controls (Nrf2+/+, ICR) received oral sulforaphane (9 mmol/daily) or vehicle before (-5, -3, -1 days) hyperoxia or air exposure (3 days), and lung injury and gene expression changes were assessed. Sulforaphane significantly reduced hyperoxia-induced airway injury, inflammation, and mucus hypersecretion in Nrf2+/+ mice while relatively marginal treatment effect was found in Nrf2-/- mice. Sulforaphane significantly altered expression of lung genes associated with oxidative phosphorylation and mitochondrial dysfunction (Atp2a2, Cox7a1, Ndufa1) basally and cell function/cycle and protein metabolism (Actr1a, Wasf2, Ccne1, Gtpbp4) after hyperoxia in Nrf2+/+ mice. Nrf2-dependently modulated lung genes by sulforaphane and hyperoxia were associated with tissue development and hereditary disorders (Slc25a3, Pccb, Psmc3ip). Results demonstrate preventive roles of sulforaphane against oxidant lung injury in mice, and reveal potential downstream mechanisms. Our observations also suggest Nrf2-independent mechanisms of sulforaphane in prevention of acute lung injury.

2015-06-01 | GSE58654 | GEO

Response to oxaliplatin in CCD-18Co

Project description:Response to oxaliplatin in CCD-18Co

| PRJNA750430 | ENA